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手術所見：2020 年 7 月 8 日、全身麻酔下で右乳房全
摘術および横軸腹直筋(Transverse Rectus Abdominal 
musculocutaneous flap: TRAM)皮弁＋supercharge 術
を 施 行 し た 。 乳 腺 外 科 医 に よ り skin sparing 
mastectomy（SSM）が施行されたあと、当科と交代した。










































(Vertical Rectus Abdominal musculocutaneous flap: 
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手術初見：2020 年 2 月 12 日、全身麻酔下にて手術















れぞれ術後 7 日、10 日に抜去し、術後 11 日目に退院
となった。術後 10 ヶ月目となるが、再建乳房に硬結は




































は、下腹壁動 静脈を血管茎とす る遊離皮弁（ Deep 




























































































死が 19 例中 3 例との報告が見られた [9]．当科の術後
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in Breast Reconstruction 
Junko OKANO1), Yoshihisa SUZUKI1), Atsuhiro ARAKAWA1), Shuichi OGINO1), Yuki KAWAI2), 
Kaori TOMITA2), Mina KITAMURA2), Tsuyoshi YAMAGUCHI2) and Masaji TANI 2) 
1) Department of Plastic and Reconstructive Surgery, Shiga University of Medical Science 
2) Division of Breast and General Surgery, Department of Surgery, Shiga University of Medical Science 
 
Abstract  With the onset of insurance coverage in 2013, implant-based techniques had been popular for breast reconstruction 
in Japan until fairly recently. However, possible complications of non-Hodgkin’s lymphoma caused by implant materials led 
a recall of textured-typed implants for breast reconstruction. Such situation led patients head for breast reconstruction using 
autologous tissue. In case of well-developed breasts, either rectus abdominal musculocutaneous flap or deep inferior epigastric 
perforator flap is frequently selected for breast reconstruction. The former flap is well-vascularized but rectus abdominal 
muscle is used to transpose the flap, which could cause the herniation of the abdominal wall as a complication at late-stage. 
In the latter flap, since abdominal fat tissue is used, reconstructed breasts are similar to original breasts, while operation periods 
are relatively long in order to anastomose vessels under microscopy. Besides, thrombosis in anastomosed vessels could cause 
the total necrosis of reconstructed breasts. 
To overcome the disadvantages of the both methods, rectus abdominal musculocutaneous flaps anastomosed with vessels in 
the recipient region (i.e., Supercharged flap) have been developed. Here, we will describe seven cases with supercharged flaps 
to reconstruct breasts performed in our hospital. 
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